Announced Fri, 10 Apr · 17:20 IST
Promoters confirm no share encumbrance in FY26
Ownership Changes View source PDF
VAISHALI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+8.4%1-day move
₹6.09
prior close
₹6.19
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.7-3.2-3.1-3.1+8.4+7.6+23.2+26.4+46.5+36.8+23.2+15.8+19.5+30.2
Up moveDown movePending
AI summary
The Promoter and Promoter Group of Vaishali Pharma, including Chairman & MD Atul Vasani, have confirmed that no encumbrance (pledge or lien) was created on the company's shares during the financial year ending 31 March 2026. This is a routine annual compliance filing under SEBI's Takeover Regulations, indicating the promoter group did not pledge any of their holdings during the year.
Likely market impact
Neutral to mildly positive — confirms no new share pledging by promoters, reducing near-term margin call or governance risk for shareholders.